Pharma/Life Sciences Industry Outlook

Master the dynamic challenges of the pharma industry

The pharmaceuticals industry faces complex regulatory challenges and scrutiny whilst also striving to innovate and maintain patient safety. With disruptions caused by the pandemic and supply chain issues, traceability and transparency are increasingly important for quality control and regulatory compliance, necessitating standardised reporting mechanisms to build a resilient supply chain. This report addresses these challenges and aims to assist businesses in navigating the evolving regulatory landscape and mitigating emerging risks.

The European Commission’s proposed requirements for pharmaceutical companies in the EU aim to enhance the accessibility and affordability of medicines. Compliance with these updates will require increased transparency and a focus on supply chain agility. The pharma industry also faces challenges from its overreliance on developing countries for ingredient supplies, with a high prevalence of counterfeit or substandard medical products...

Download the report here